Compare INMB & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INMB | BTMD |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.9M | 46.2M |
| IPO Year | 2018 | 2021 |
| Metric | INMB | BTMD |
|---|---|---|
| Price | $2.39 | $1.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $5.40 | $2.83 |
| AVG Volume (30 Days) | ★ 342.0K | 301.8K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 11.85 | ★ 722.22 |
| EPS | N/A | ★ N/A |
| Revenue | $50,000.00 | ★ $192,219,000.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | N/A | $6.58 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 257.14 | N/A |
| 52 Week Low | $1.09 | $1.27 |
| 52 Week High | $2.48 | $3.61 |
| Indicator | INMB | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 71.42 | N/A |
| Support Level | $1.37 | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.13 | 0.00 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 87.50 | 0.00 |
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.